NELF-D Antibodies

Santa Cruz Biotechnology provides a broad selection of NELF-D monoclonal antibodies for research focused on understanding transcriptional regulation mechanisms. NELF-D monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NELF-D, a key component of the negative elongation factor (NELF) complex, plays a crucial role in regulating transcriptional elongation by pausing RNA polymerase II. NELF-D is essential for the proper expression of genes involved in various cellular processes, including differentiation and response to stress. Understanding NELF-D function provides insights into fundamental mechanisms of gene regulation and their implications in diseases. Researchers can explore transcription regulation dynamics and cellular function through precise detection and analysis of NELF-D. Advanced research techniques supported by NELF-D monoclonal antibodies enable detailed investigation of transcriptional control mechanisms. Extensive characterization of NELF-D activity contributes to expanding knowledge of gene expression regulation. Santa Cruz Biotechnology monoclonal antibodies for NELF-D support researchers worldwide in advancing our understanding of transcriptional control and its impact on human health.